A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma Meeting Abstract
| Authors: | Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; Crago, A. M.; Yoon, S. S.; Ariyan, C. E.; Hwang, S.; Erinjeri, J. P.; Antonescu, C. R.; Qin, L. X.; Tap, W. D.; D'Angelo, S. P. |
| Abstract Title: | A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 580s |
| Language: | English |
| ACCESSION: | WOS:000442916003599 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.11516 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11516 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
